BIOFIRE FILMARRAY panels provide comprehensive identification for diverse infectious disease and biothreat applications, ensuring timely and informed decisions.

• The FilmArray® BioThreat Panel offers fast, comprehensive identification of 17 biothreat agents from a single environmental sample in about an hour.
• The FilmArray® Global Fever Panel – RUO (Research Use Only) is designed for the detection of agents causing global fevers, supporting surveillance and research.
• The BioFire® COVID-19 Test provides fast, qualitative detection of SARS-CoV-2 RNA from nasopharyngeal swabs, crucial for swift pandemic response (Emergency Use Authorization).
• The BioFire® Global Fever Panel is an IVD panel designed for the detection of common fever-causing pathogens, aiding in clinical diagnosis.
• The BioFire® Global Fever Special Pathogens Panel is an IVD panel that identifies 22 pathogens causing fever, including many highly concerning biothreat agents.
• The FilmArray® Food & Water Panel enables fast and accurate identification of various pathogens and toxins in environmental food and water samples, vital for public health surveillance.
• The FilmArray® NGDS Warrior Panel (IVD) is a DoD-controlled panel for IVD use, providing comprehensive detection for specific biothreat targets relevant to military and government needs.
• The BIOFIRE® Respiratory 2.1 (RP2.1) Panel is a frontline test to help clinicians more quickly diagnose URTIs, including COVID-19, influenza, RSV, and many others. The multiplex PCR panel identifies 22 pathogen targets within a time frame that potentially facilitates better-informed diagnosis and treatment of patients.
• The BIOFIRE® Blood Culture Identification 2 (BCID2) Panel is designed for positive blood cultures, testing for 43 targets related to bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes.
• The BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel tests stool specimens for 22 common gastrointestinal pathogens, ensuring appropriate treatment and improving patient management through rapid identification.
• The BIOFIRE® FILMARRAY® Pneumonia (PN) Panel identifies 33 clinically relevant targets from sputum and bronchoalveolar lavage samples. For 15 bacteria, it provides semi-quantitative results, helping differentiate between colonizers and pathogens to guide treatment.
• The BIOFIRE® FILMARRAY® Meningitis/Encephalitis (ME) Panel analyzes cerebrospinal fluid (CSF) for 14 common viral, bacterial, and yeast pathogens that cause central nervous system infections, enabling faster decisions on appropriate therapy to prevent complications.
• The BIOFIRE® Joint Infection (JI) Panel tests synovial fluid for 39 targets, including Gram-positive and Gram-negative bacteria, yeast, and antimicrobial resistance genes commonly associated with joint infections, aiming to reduce the time to effective therapy through rapid pathogen identification.
• The BIOFIRE® GI Panel Mid will test stool specimens for a comprehensive set of 11 gastrointestinal pathogens, including common targets associated with gastroenteritis.